Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis Type 2”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Not applicableStudy completedNCT02246231
What this trial is testing

Effect of Implant Position on Magnetic Resonance Image Distortion

Who this might be right for
Neurofibromatosis Type 2
Manchester University NHS Foundation Trust 5
Early research (Phase 1)Active Not RecruitingNCT04857372
What this trial is testing

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Who this might be right for
Mesothelioma
Novartis Pharmaceuticals 137
Testing effectiveness (Phase 2)Ended earlyNCT01345136
What this trial is testing

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Who this might be right for
Neurofibromatosis Type 2Neuroma, Acoustic
Jonsson Comprehensive Cancer Center 4
Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Not applicableUnknownNCT05821790
What this trial is testing

Role of the Tumor Microenvironment in Aggressive Meningiomas

Who this might be right for
Meningioma
Assistance Publique - Hôpitaux de Paris 40
Early research (Phase 1)Not Yet RecruitingNCT06502171
What this trial is testing

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
Girish Dhall, MD 30
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Not applicableEnded earlyNCT01864291
What this trial is testing

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 9
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Not applicableStudy completedNCT03617276
What this trial is testing

Reliability of Functional Outcome Measures in Neurofibromatosis 2

Who this might be right for
Neurofibromatosis 2
Guy's and St Thomas' NHS Foundation Trust 30
Early research (Phase 1)Looking for participantsNCT05873686
What this trial is testing

Clinical Study of NXP900 in Subjects With Advanced Cancers

Who this might be right for
Advanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more
Nuvectis Pharma, Inc. 140
Early research (Phase 1)Study completedNCT00030043
What this trial is testing

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

Who this might be right for
Neurofibromatosis 2
FDA Office of Orphan Products Development 10
Not applicableNo Longer AvailableNCT02589912
What this trial is testing

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Who this might be right for
Neurofibromatosis Type 2Severe Profound Sensorineural Hearing Loss
Massachusetts Eye and Ear Infirmary
Not applicableLooking for participantsNCT01885767
What this trial is testing

Neurofibromatosis (NF) Registry Portal

Who this might be right for
Neurofibromatosis 1Neurofibromatosis 2Schwannomatosis
The Children's Tumor Foundation 20,000
Not applicableUnknownNCT04890132
What this trial is testing

Vestibular Precision: Physiology & Pathophysiology

Who this might be right for
Vestibular SchwannomaInner Ear DiseaseDizziness+2 more
Massachusetts Eye and Ear Infirmary 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03079999
What this trial is testing

Study of Aspirin in Patients With Vestibular Schwannoma

Who this might be right for
Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2
Massachusetts Eye and Ear Infirmary 97
Load More Results